Healthequity Inc
NASDAQ:HQY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
62.44
104.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Healthequity Inc
Healthequity Inc
Selling, General & Administrative
Healthequity Inc
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Healthequity Inc
NASDAQ:HQY
|
Selling, General & Administrative
-$207.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-30%
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Selling, General & Administrative
-$53.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
|
Centene Corp
NYSE:CNC
|
Selling, General & Administrative
-$12.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-22%
|
|
|
Molina Healthcare Inc
NYSE:MOH
|
Selling, General & Administrative
-$4.4B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-15%
|
|
|
Humana Inc
NYSE:HUM
|
Selling, General & Administrative
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Elevance Health Inc
NYSE:ELV
|
Selling, General & Administrative
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Healthequity Inc
Glance View
Healthequity Inc. is a prominent player in the health benefits space, focusing on health savings and spending accounts that empower individuals and families to manage their healthcare expenses more effectively. The company stands at the intersection of healthcare and technology, providing innovative solutions that facilitate tax-advantaged savings for medical expenses through Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs). Founded in 2002, Healthequity has experienced robust growth driven by a growing awareness of the importance of consumer-directed healthcare and increasing employer sponsorship of HSAs as a means to attract and retain talent. By offering seamless digital platforms that simplify account management, Healthequity not only enhances user experience but also addresses the evolving needs of a healthcare landscape that calls for greater financial literacy among consumers. For investors looking for a company that capitalizes on the shifting dynamics of healthcare financing, Healthequity represents an attractive opportunity. With a reliable revenue model grounded in fees from account holders and interest on cash balances, the company continues to expand its market share through strategic acquisitions and partnerships. The shift towards high-deductible health plans (HDHPs) is driving demand for HSAs, a trend that aligns well with Healthequity's business model. Moreover, as the healthcare industry increasingly prioritizes cost transparency and consumer engagement, Healthequity is well-positioned to grow its footprint, securing a strong competitive advantage. Overall, investing in Healthequity means backing a company that is not only instrumental in reshaping the consumer healthcare experience but is also strategically poised for long-term success in a burgeoning market.
See Also
What is Healthequity Inc's Selling, General & Administrative?
Selling, General & Administrative
-207.4m
USD
Based on the financial report for Jul 31, 2024, Healthequity Inc's Selling, General & Administrative amounts to -207.4m USD.
What is Healthequity Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-30%
Over the last year, the Selling, General & Administrative growth was -20%. The average annual Selling, General & Administrative growth rates for Healthequity Inc have been -13% over the past three years , -25% over the past five years , and -30% over the past ten years .
You don't have any saved screeners yet
